Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients
Authors
Keywords
EGFR, Mutation, HPV16, Correlation
Journal
TUMOR BIOLOGY
Volume 37, Issue 7, Pages 9089-9098
Publisher
Springer Nature
Online
2016-01-14
DOI
10.1007/s13277-016-4789-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications
- (2015) Sureewan Bumrungthai et al. Journal of Translational Medicine
- Emerging Biological Treatments for Uterine Cervical Carcinoma
- (2014) Patrizia Vici et al. Journal of Cancer
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategies
- (2013) Chetan Yewale et al. BIOMATERIALS
- Oncogenic mutations in cervical cancer
- (2013) Alexi A. Wright et al. CANCER
- Comment on: EGFR mutational status in Brazilian patients with penile carcinoma
- (2013) Alice Muglia Thomaz da Silva et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Epidermal growth factor receptor mutations in lung adenocarcinoma
- (2013) Markus D Siegelin et al. LABORATORY INVESTIGATION
- Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
- (2012) M. Kearse et al. BIOINFORMATICS
- Developments in the systemic treatment of metastatic cervical cancer
- (2012) Giannis Mountzios et al. CANCER TREATMENT REVIEWS
- Cancer mortality in India: a nationally representative survey
- (2012) Rajesh Dikshit et al. LANCET
- Epidermal growth factor receptor as a biomarker for cervical cancer
- (2011) T. Soonthornthum et al. ANNALS OF ONCOLOGY
- EGFR signaling regulates cell proliferation, differentiation and morphogenesis during planarian regeneration and homeostasis
- (2011) Susanna Fraguas et al. DEVELOPMENTAL BIOLOGY
- Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer
- (2011) Marlies Schrevel et al. MODERN PATHOLOGY
- HPV typing and its relation with apoptosis in cervical carcinoma from Indian population
- (2011) M. Shabbir Alam et al. TUMOR BIOLOGY
- Lack in Efficacy for Imatinib Mesylate as Second-Line Treatment of Recurrent or Metastatic Cervical Cancer Expressing Platelet-Derived Growth Factor Receptor α
- (2010) Myrna Candelaria et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma
- (2010) S. J. Mehdi et al. MEDICAL ONCOLOGY
- The different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of China
- (2010) M. LI et al. NEOPLASMA
- Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
- (2009) Adhemar Longatto-Filho et al. BMC CANCER
- Novel chemotherapy approaches for cervical cancer
- (2009) Sujana Movva et al. CANCER
- Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer
- (2009) M. G. Noordhuis et al. CLINICAL CANCER RESEARCH
- Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial
- (2009) Fernando Rivera et al. Expert Review of Anticancer Therapy
- Epidermal growth factor receptor expression affects the efficacy of the combined application of saponin and a targeted toxin on human cervical carcinoma cells
- (2009) Diana Bachran et al. INTERNATIONAL JOURNAL OF CANCER
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
- (2008) Alberto F. Sobrero et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
- (2007) A. Goncalves et al. GYNECOLOGIC ONCOLOGY
- Absence of epidermal growth factor receptor mutations in cervical cancer
- (2007) H. ARIAS-PULIDO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started